(KR) Kroger - Ratings and Ratios
Grocery, Pharmacy, Fuel, Apparel, Produce
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.14% |
| Yield on Cost 5y | 5.60% |
| Yield CAGR 5y | 15.73% |
| Payout Consistency | 62.4% |
| Payout Ratio | 28.4% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 22.2% |
| Value at Risk 5%th | 34.2% |
| Relative Tail Risk | -6.51% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.04 |
| Alpha | 1.97 |
| CAGR/Max DD | 0.88 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.406 |
| Beta | -0.233 |
| Beta Downside | -0.147 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.77% |
| Mean DD | 5.52% |
| Median DD | 5.27% |
Description: KR Kroger December 04, 2025
The Kroger Co. (NYSE:KR) is a U.S.-based food and drug retailer that operates four primary formats: combination food-and-drug stores, multi-department stores, marketplace stores, and price-impact warehouse stores. Across these formats the company offers a broad assortment that includes natural and organic foods, pharmacy services, general merchandise, apparel, electronics, and fuel, while also manufacturing many of its private-label food products and selling them through both brick-and-mortar locations and online channels.
Key performance indicators from recent filings show that Kroger’s FY 2023 comparable sales grew roughly 4.5% year-over-year, driven in part by a 12% surge in digital sales and a 3.2% increase in fuel-center volume. The retailer’s operating margin hovered around 3.0%, reflecting cost-inflation pressures common in the grocery sector. A critical economic driver is consumer inflation, which tends to shift demand toward private-label and value-priced items-a trend Kroger has capitalized on through its Simple Truth and Private Selection brands. Additionally, the broader food-retail industry is sensitive to commodity price volatility and labor cost dynamics, both of which can materially affect Kroger’s cost structure.
If you’re looking for a deeper, data-driven assessment of KR’s valuation and risk profile, ValueRay’s analyst notes provide a concise next step.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (789.0m TTM) > 0 and > 6% of Revenue (6% = 8.83b TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA 0.86pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -1.51% (prev 5.84%; Δ -7.35pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.12 (>3.0%) and CFO 6.04b > Net Income 789.0m (YES >=105%, WARN >=100%) |
| Net Debt (21.24b) to EBITDA (5.29b) ratio: 4.01 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.88 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (655.0m) change vs 12m ago -10.03% (target <= -2.0% for YES) |
| Gross Margin 22.70% (prev 22.62%; Δ 0.08pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 258.6% (prev 240.1%; Δ 18.49pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.05 (EBITDA TTM 5.29b / Interest Expense TTM 714.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.37
| (A) -0.04 = (Total Current Assets 15.99b - Total Current Liabilities 18.22b) / Total Assets 51.44b |
| (B) 0.55 = Retained Earnings (Balance) 28.20b / Total Assets 51.44b |
| (C) 0.03 = EBIT TTM 1.47b / Avg Total Assets 56.93b |
| (D) 0.66 = Book Value of Equity 29.51b / Total Liabilities 44.40b |
| Total Rating: 2.37 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 50.51
| 1. Piotroski 5.0pt |
| 2. FCF Yield 3.57% |
| 3. FCF Margin 1.53% |
| 4. Debt/Equity 3.58 |
| 5. Debt/Ebitda 4.01 |
| 6. ROIC - WACC (= 0.96)% |
| 7. RoE 9.41% |
| 8. Rev. Trend -5.43% |
| 9. EPS Trend 16.59% |
What is the price of KR shares?
Over the past week, the price has changed by +0.67%, over one month by -7.17%, over three months by -5.10% and over the past year by +4.50%.
Is KR a buy, sell or hold?
- Strong Buy: 9
- Buy: 3
- Hold: 12
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the KR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 73.8 | 17.7% |
| Analysts Target Price | 73.8 | 17.7% |
| ValueRay Target Price | 68.5 | 9.2% |
KR Fundamental Data Overview December 27, 2025
P/E Trailing = 55.6903
P/E Forward = 11.7647
P/S = 0.2833
P/B = 5.6554
P/EG = 1.2447
Beta = 0.577
Revenue TTM = 147.22b USD
EBIT TTM = 1.47b USD
EBITDA TTM = 5.29b USD
Long Term Debt = 14.55b USD (from longTermDebt, last quarter)
Short Term Debt = 2.60b USD (from shortTermDebt, last quarter)
Debt = 25.20b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 21.24b USD (from netDebt column, last quarter)
Enterprise Value = 62.95b USD (41.70b + Debt 25.20b - CCE 3.96b)
Interest Coverage Ratio = 2.05 (Ebit TTM 1.47b / Interest Expense TTM 714.0m)
FCF Yield = 3.57% (FCF TTM 2.25b / Enterprise Value 62.95b)
FCF Margin = 1.53% (FCF TTM 2.25b / Revenue TTM 147.22b)
Net Margin = 0.54% (Net Income TTM 789.0m / Revenue TTM 147.22b)
Gross Margin = 22.70% ((Revenue TTM 147.22b - Cost of Revenue TTM 113.81b) / Revenue TTM)
Gross Margin QoQ = 21.03% (prev 23.01%)
Tobins Q-Ratio = 1.22 (Enterprise Value 62.95b / Total Assets 51.44b)
Interest Expense / Debt = 0.58% (Interest Expense 146.0m / Debt 25.20b)
Taxrate = 26.54% (-475.0m / -1.79b)
NOPAT = 1.08b (EBIT 1.47b * (1 - 26.54%))
Current Ratio = 0.88 (Total Current Assets 15.99b / Total Current Liabilities 18.22b)
Debt / Equity = 3.58 (Debt 25.20b / totalStockholderEquity, last quarter 7.04b)
Debt / EBITDA = 4.01 (Net Debt 21.24b / EBITDA 5.29b)
Debt / FCF = 9.45 (Net Debt 21.24b / FCF TTM 2.25b)
Total Stockholder Equity = 8.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.53% (Net Income 789.0m / Total Assets 51.44b)
RoE = 9.41% (Net Income TTM 789.0m / Total Stockholder Equity 8.38b)
RoCE = 6.39% (EBIT 1.47b / Capital Employed (Equity 8.38b + L.T.Debt 14.55b))
RoIC = 4.34% (NOPAT 1.08b / Invested Capital 24.82b)
WACC = 3.38% (E(41.70b)/V(66.90b) * Re(5.16%) + D(25.20b)/V(66.90b) * Rd(0.58%) * (1-Tc(0.27)))
Discount Rate = 5.16% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -4.95%
[DCF Debug] Terminal Value 78.25% ; FCFE base≈2.23b ; Y1≈2.22b ; Y5≈2.34b
Fair Price DCF = 65.47 (DCF Value 41.44b / Shares Outstanding 632.8m; 5y FCF grow -0.92% → 3.0% )
EPS Correlation: 16.59 | EPS CAGR: 3.89% | SUE: 1.05 | # QB: 1
Revenue Correlation: -5.43 | Revenue CAGR: 0.65% | SUE: -0.89 | # QB: 0
EPS next Quarter (2026-04-30): EPS=1.68 | Chg30d=+0.021 | Revisions Net=+7 | Analysts=16
EPS next Year (2027-01-31): EPS=5.30 | Chg30d=+0.024 | Revisions Net=+9 | Growth EPS=+10.4% | Growth Revenue=+2.0%
Additional Sources for KR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle